The Expansion of College Education in the United States: Is There Evidence of Declining Cohort Quality?

This paper documents the expansion of college education in the U.S. and examines to what extent the increase in the number of college graduates may have lead to a decline in the average quality of college graduates. Using the 1940-1990 Census, we compare across birth year cohorts with varying levels of college completion. We find some weak evidence that college graduate men from highly educated cohorts earn a relatively smaller wage premium even controlling for the relative supply effect. However, these cohort quality effects account for only a small fraction of the recent fluctuation in the college wage premium.

Investigation of the physicochemical features and mixing of East/Japan Sea Intermediate Water: An isopycnic analysis approach

We present spatial distributions of the mixing ratio and properties of the East/Japan Sea Intermediate Water (ESIW) at its core density layer (σθ = 27.2–27.3) based on high-quality hydrographic data observed in the East/Japan Sea (EJS) during summer 1999. ESIW is defined as a source water type showing minimum salinity and maximum dissolved oxygen concentration. ESIW plays an important role in supplying dissolved oxygen and transporting anthropogenic carbon into the intermediate/deep layers in EJS. Studying the ESIW formation and distribution processes may provide insights on EJS\u27s shallow- to mid-depth thermohaline circulation and recent ocean changes. Here, we combine the previously estimated mixing ratio of ESIW, based on Optimum Multi-Parameter (OMP) analysis, and its physicochemical properties, such as pressure, dissolved oxygen, and phosphate, interpolated onto several isopycnic surfaces (σθ = 27.20, 27.25, and 27.30). The physicochemical properties of ESIW show steep north-south gradients across the subpolar front at 40–41°N. Higher dissolved oxygen concentrations (≥335 μmol kg–1) of ESIW are found in the western Japan Basin particularly off the Primorye coast, indicating a potential source region. The spatial and depth distributions of apparent oxygen utilization (AOU) on the ESIW isopycnic surfaces indicate that the subduction of ESIW occurs at 131–133°E (Ulleung Basin) across the subpolar front to the south. The density layer of ESIW shoals near the Korean coast in the Ulleung Basin, implying a potential link to coastal upwelling. The relative age of ESIW at its core layer is estimated from the oxygen utilization rate and AOU. The correlation between the pCFC12 and relative ages, and AOU estimated at 90% surface water oxygen saturation condition suggests a decadal-scale ventilation of ESIW (≤24 years). Younger waters at the ESIW coexist with the high-salinity intermediate water at the same density layer in the eastern Japan Basin. Our analysis suggests that ESIW is sensitive to climate forcing and an important shallow- to mid-depth thermohaline circulation component of EJS

Poly(L-histidine)-tagged 5-aminolevulinic acid prodrugs: new photosensitizing precursors of protoporphyrin IX for photodynamic colon cancer therapy

Renjith P Johnson,1* Chung-Wook Chung,2* Young-Il Jeong,2 Dae Hwan Kang,2 Hongsuk Suh,3 Il Kim,11WCU Centre for Synthetic Polymer Bioconjugate Hybrid Materials, Department of Polymer Science and Engineering, Pusan National University, Pusan, 2National Research and Development Center for Hepatobiliary Cancer, Pusan National University, Yangsan Hospital, Yangsan, Gyeongnam, 3Department of Chemistry and Chemistry Institute for Functional Materials, Pusan National University, Pusan, Korea*These authors contributed equally to this workBackground: 5-Aminolevulinic acid (ALA) and its derivatives have been widely used in photodynamic therapy. The main drawback associated with ALA-based photodynamic therapy (ALA-PDT) and ALA fluorescence diagnosis results from the hydrophilic nature of ALA and lack of selectivity for tumor versus nontumor cells. The application of certain triggers, such as pH, into conventional sensitizers for controllable 1O2 release is a promising strategy for tumor-targeted treatment.Methods: A series of pH-sensitive ALA-poly(L-histidine) [p(L-His)n] prodrugs were synthesized via ring opening polymerization of 1-benzyl-N-carboxy-L-histidine anhydride initiated by the amine hydrochloride group of ALA itself. As an alternative to ALA for PDT, the synthesized prodrugs were used to treat a cultured human colon cancer HCT116 cell line under different pH conditions. The effect of ALA-p(L-His)n derivatives was evaluated by monitoring the fluorescence intensity of protoporphyrin IX, and measuring the cell survival rate after suitable light irradiation.Results: The cytotoxicity and dark toxicity of ALA and synthesized ALA-p(L-His) derivatives in HEK293T and HCT116 cells in the absence of light at pH 7.4 and 6.8 shows that the cell viability was relatively higher than 100%. ALA-p(L-His)n showed high phototoxicity and selectivity in different pH conditions compared with ALA alone. Because the length of the histidine chain increases in the ALA-p(L-His)n prodrugs, the PDT effect was found to be more powerful. In particular, high phototoxicity was observed when the cells were treated with ALA-p(L-His)15, compared with treatment using ALA alone.Conclusion: The newly synthesized ALA-p(L-His)n derivatives are an effective alternative to ALA for enhancing protoporphyrin IX production and the selectivity of the phototoxic effect in tumor cells.Keywords: 5-aminolevulinic acid, photodynamic therapy, poly(L-histidine), bioconjugate, cancer cell

Comparing the Efficacy of Concomitant Therapy with Sequential Therapy as the First-Line Therapy of Helicobacter pylori

Background. The decline of Helicobacter pylori (H. pylori) eradication rates with standard triple therapy resulted in a search for novel therapies for first-line therapy of H. pylori infection. Aim. The aim of the study is to compare the efficacy of concomitant therapy with sequential therapy as the first-line therapy of H. pylori eradication. Methods. We reviewed medical records of patients who were confirmed to have H. pylori infection and received eradication treatment from September 2012 to March 2015. The concomitant group was treated with rabeprazole, amoxicillin, clarithromycin, and metronidazole for 7 days. The sequential group was treated with rabeprazole and amoxicillin for 5 days and then rabeprazole, clarithromycin, and metronidazole for an additional 5 days. Six weeks after the treatment period, patients in both groups underwent 13C-Urea breath test (UBT) to confirm H. pylori eradication. Results. The eradication rate was 90.3% in the concomitant group and 85.5% in the sequential group. However, the eradication rates between the two groups showed no statistical difference (P=0.343). Conclusion. No statistical difference was found in eradication rates between the two groups. However, in areas where antibiotic resistance is high, concomitant therapy may be more effective than sequential therapy for H. pylori eradication

Antitumor activity of sorafenib-incorporated nanoparticles of dextran/poly(dl-lactide-co-glycolide) block copolymer

Sorafenib-incoporated nanoparticles were prepared using a block copolymer that is composed of dextran and poly(DL-lactide-co-glycolide) [DexbLG] for antitumor drug delivery. Sorafenib-incorporated nanoparticles were prepared by a nanoprecipitation-dialysis method. Sorafenib-incorporated DexbLG nanoparticles were uniformly distributed in an aqueous solution regardless of the content of sorafenib. Transmission electron microscopy of the sorafenib-incorporated DexbLG nanoparticles revealed a spherical shape with a diameter < 300 nm. Sorafenib-incorporated DexbLG nanoparticles at a polymer/drug weight ratio of 40:5 showed a relatively uniform size and morphology. Higher initial drug feeding was associated with increased drug content in nanoparticles and in nanoparticle size. A drug release study revealed a decreased drug release rate with increasing drug content. In an in vitro anti-proliferation assay using human cholangiocarcinoma cells, sorafenib-incorporated DexbLG nanoparticles showed a similar antitumor activity as sorafenib. Sorafenib-incorporated DexbLG nanoparticles are promising candidates as vehicles for antitumor drug targeting